SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Baird Maintains Outperform, $64 Price Target As Firm Believes 'that Palforzia will experience strong uptake as Aimmune appears well positioned to help satisfy the significant unmet need in peanut allergy.'

Benzinga · 02/03/2020 14:50